Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
New migraine drugs less effective than previous generation of triptan meds: BMJ study
Fierce Pharma
Thu, 09/19/24 - 09:29 pm
migraines
BMJ
Pfizer
Nurtec
AbbVie
Ubrelvy
Eli Lilly
Reyvow
Novartis heaps pressure on Lilly with broad FDA approval for Kisqali in early breast cancer
Fierce Pharma
Tue, 09/17/24 - 11:08 pm
Novartis
FDA
Eli Lilly
breast cancer
Kisqali
ESMO 2024: Eli Lilly brings the competition to Novartis with new results in mCRPC
Clinical Trials Arena
Tue, 09/17/24 - 11:13 am
Eli Lilly
ESMO
lutetium zadavotide guraxetan
Astellas
Janssen
metastatic castration-resistant prostate cancer
FDA approves Eli Lilly's drug for eczema
Reuters
Mon, 09/16/24 - 10:16 pm
Eli Lilly
FDA
eczema
Ebgylss
How Lilly’s sustainability goals come face to face with massive growth
Pharma Voice
Thu, 09/12/24 - 10:17 am
Eli Lilly
drug manufacturing
sustainability
Lilly delivers one-two punch with 2nd tranche of positive data on weekly insulin candidate
Fierce Biotech
Wed, 09/11/24 - 11:07 pm
Eli Lilly
efsitora
diabetes
insulin
Weight-loss market to see 16 new drugs by 2029, report estimates
Reuters
Tue, 09/10/24 - 04:29 pm
weight loss
obesity
Amgen
Pfizer
Roche
Novo Nordisk
Eli Lilly
Boehinger Ingelheim
Structure Therapeutics
Viking Therapeutics
Zealand Pharma
Altimmune
Lilly-backed Superluminal raises $120M series A to bring membrane receptor drugs into the clinic
Fierce Biotech
Mon, 09/9/24 - 10:46 am
Eli Lilly
Superluminal Medicines
funding
small molecule drugs
57 Million Eligible For GLP-1 Drug Coverage In U.S. And That’s Just Those Under 65
Forbes
Thu, 09/5/24 - 10:29 pm
obesity
GLP-1
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
insurers
Eli Lilly says experimental insulin could mean 313 fewer injections per year
Quartz
Thu, 09/5/24 - 11:50 am
Eli Lilly
long-acting insulin
diabetes
clinical trials
efsitora
Eli Lilly partners with AI-focused Genetic Leap to develop RNA-based drugs
Reuters
Thu, 09/5/24 - 11:38 am
Eli Lilly
Genetic Leap
drug development
artificial intelligence
BioAge files for IPO, plans pair of midstage obesity trials
Fierce Biotech
Wed, 09/4/24 - 11:40 am
BioAge Labs
IPOs
Eli Lilly
obesity
clinical trials
Eli Lilly bets $1B in biobucks on Haya to scour dark genome for obesity targets
Fierce Biotech
Wed, 09/4/24 - 11:37 am
Eli Lilly
Haya Therapeutics
dark genome
obesity
drug discovery
New research could ease concerns over suicide risk of obesity drugs
BioPharma Dive
Tue, 09/3/24 - 05:58 pm
obesity
suicide
GLP-1
Novo Nordisk
Eli Lilly
Ozempic
Wegovy
Mounjaro
Zepbound
Eli Lilly partner Hutchmed scraps China stomach cancer filing as approval seems unlikely
Fierce Pharma
Fri, 08/30/24 - 11:40 am
Hutchmed
Eli Lilly
Fruzaqla
China
stomach cancer
Eli Lilly’s lauded discount of its obesity drug Zepbound comes with caveats
Stat
Wed, 08/28/24 - 09:24 pm
Eli Lilly
Zepbound
DTC
Eli Lilly rolls out direct patient access to weight loss star Zepbound—at a deep discount
Fierce Pharma
Tue, 08/27/24 - 11:51 am
Eli Lilly
Zebound
DTC
Lilly launches smallest single-dose vials of Zepbound for $399
Reuters
Tue, 08/27/24 - 11:16 am
Eli Lilly
Zepbound
Mixed reactions among HCPs as lecanemab and donanemab secure FDA approval for Alzheimer's treatment
Pharmaphorum
Mon, 08/26/24 - 10:14 am
Alzheimer's disease
physicians
Eli Lilly
Kisunla
donanemab
lecanemab
Eli Lilly seeks new angle on high-value target, tapping Oblique for antibody discovery push
Fierce Biotech
Thu, 08/22/24 - 11:55 am
Eli Lilly
Oblique Therapeutics
AbiProt
drug discovery
antibodies
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »